查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2083915

人工尿道括約肌市場：2026-2032年全球市場預測（依產品類型、組件類型、作用機制、材質類型、性別、通路、應用及最終用戶分類）

Artificial Urinary Sphincters Market by Product Type, Component Type, Mechanism of Action, Material Type, Gender, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工尿道括約肌市場將成長至 7.6318 億美元，複合年成長率為 7.46%。

主要市場統計數據
基準年 2025 460,990,000 美元
預計年份：2026年 4.9751億美元
預測年份 2032 7.6318億美元
複合年成長率 (%) 7.46%

人工尿道括約肌（AUS）是一種可植入式尿失禁治療裝置，主要用於治療中度至重度應力性尿失禁，特別適用於接受過前列腺癌治療或其他導致括約肌功能受損的手術的男性。此類裝置具有重要的臨床意義，因為應力性尿失禁會限制患者的活動能力、工作、睡眠、心理健康和長期生活品質，因此需要可靠的泌尿系統植入和尿失禁重組治療。

在泌尿系統指引和同儕審查的臨床實務中，對於根治性攝護腺切除術後出現嚴重尿失禁的男性患者，人工尿道括約肌植入術（AUS）仍是標準治療方法。人口老化、前列腺癌存活率提高、人們對生活品質的期望不斷成長以及泌尿系統重組服務的普及，都推動了AUS的需求成長。此外，外科醫師的培訓、保險覆蓋範圍、感染控制方案以及器械的耐用性也是AUS需求成長的重要因素。人工尿道括約肌植入術需要合適的患者、精湛的手術技巧、對患者進行器械使用方面的教育，以及終身隨訪，以解決諸如再次手術、感染疾病、侵蝕或機械性能等問題。

人工尿道括約肌（AUS）領域的變革性變化

人工尿道括約肌（AUS）領域的研究重點正從手術可行性轉向可衡量的治療效果、患者自述的改善情況以及生命週期管理。醫院和門診手術中心越來越重視併發症減少、再入院避免、感染預防和裝置長期性能，術前諮詢和術後後續觀察也成為AUS手術實施的核心環節。

人工智慧（AI）的累積影響

人工智慧（AI）不會取代人工尿道括約肌，但它正開始影響人工尿道括約肌植入候選者的治療路徑。人工智慧驅動的分析整合了年齡、放射治療史、糖尿病史、尿道手術史、抗凝血治療情況、身體機能、操作裝置的認知能力以及漏尿嚴重程度等因素，進行風險分層，從而識別可能需要更詳細諮詢或重組手術專家的患者。

主要區域洞察：亞太地區、北美地區、拉丁美洲地區、歐洲地區、中東和非洲地區

北美仍然是人工尿道括約肌最成熟的區域市場，這得益於該地區較高的前列腺癌存活率、先進的泌尿系統重組網路以及廣泛應用的基於指南的治療流程。該地區受益於大學附屬醫院、門診手術中心、結構化的尿失禁護理以及完善的植入式泌尿系統器械報銷機制。美國是一個特別重要的市場，大規模泌尿系統集團、三級醫療機構、癌症倖存者支持計畫以及公立和私立保險公司已經為人工尿道括約肌（AUS）的植入、再次手術、感染疾病管理和療效監測建立了完善的系統。同時，加拿大的醫療服務取得則受到公共資助的醫療路徑和省級外科系統的影響。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在歐盟和七國集團（G7）國家，人口老化、前列腺癌診斷和治療率高、醫療技術評估流程完善以及泌尿系統重組手術資源豐富，推動了對人工尿道括約肌（AUS）的需求。在這些市場，臨床證據、醫療設備安全性、外科醫師資格認證、報銷理由、感染預防和上市後監測都備受重視。雖然北約成員國身分本身並非醫療採購框架，但許多北約成員國與高所得市場重疊，標準化採購、醫院品管系統、軍人和退伍軍人醫療網路以及先進的泌尿功能管理診療路徑都會影響人工尿道括約肌（AUS）植入和再次手術服務的可及性。

對澳洲主要市場關鍵國家的洞察

美國是人工尿道括約肌（AUS）的主要市場，這得益於其高水平的外科手術技術、全面的前列腺癌倖存者護理、廣泛的泌尿系統重組外科經驗以及眾多開展植入手術的泌尿系統。加拿大緊隨其後，其完善的公共資助醫療體係受各省醫療能力、轉診模式和等待時間的影響。在墨西哥和巴西，需求主要來自於設有泌尿系統重組外科部門且能夠購買植入式醫療設備的私立醫院、大型大學醫院以及大都會圈的專科診所。在拉丁美洲，醫療服務取得與私人保險、都市區專科醫療機構的集中程度以及長期再次手術護理能力密切相關。

為行業領導者提供的實用建議

產業領導者應優先考慮基於證據的差異化，而非僅依賴設備知名度。最有效的策略是收集長期真實世界數據，以評估不同病患小組（包括有放射治療史、糖尿病史、尿道狹窄史或複雜重建需求的男性）在改善尿失禁、降低再次手術率、減少感染疾病、侵蝕、提高設備使用壽命、提升患者滿意度、減少尿墊使用量以及降低重組成本方面的效果。

調查方法

本執行摘要是基於對評估泌尿系統醫療設備市場時常用的循證來源的系統性回顧，包括泌尿科指南、關於尿道括約肌結果的同行評審研究、監管和報銷背景、醫院採用趨勢、前列腺癌倖存者趨勢、人口老齡化指標以及有關當地醫療保健基礎設施的資訊來源。

結論：人工尿道括約肌的未來

人工尿道括約肌在治療重度應力性尿失禁方面已佔據穩固地位，尤其是在前列腺癌治療後，其臨床療效已得到證實。人口老化、泌尿系統護理著重於倖存者支持、患者對恢復尿功能的需求，以及在保守治療或微創手術效果不佳時對專業重組方案的持續需求，都支撐著這一市場的長期重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 人工尿道括約肌市場：依產品類型分類

  • 單袖人工尿道括約肌
  • 雙袖人工尿道括約肌

第8章：人工尿道括約肌市場：依組件類型分類

  • 閉塞袖帶
  • 壓力調節氣球
  • 控制泵浦
  • 電控系統

第9章：人工尿道括約肌市場：依作用機轉分類

  • 液壓控制
  • 機械壓縮系統
  • 電子機械/感測器控制系統

第10章：人工尿道括約肌市場：依材料類型分類

  • 矽酮
  • 聚氨酯
  • 生物相容性聚合物

第11章：人工尿道括約肌市場：依性別分類

  • 女士
  • 男性

第12章：人工尿道括約肌市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上銷售

第13章 人工尿道括約肌市場：依應用領域分類

  • 神經源性膀胱功能障礙
  • 應力性尿失禁

第14章：人工尿道括約肌市場：依最終用戶分類

  • 門診手術中心
    • 獨立的
    • 醫院附屬機構
  • 診所
    • 全科診所
    • 泌尿系統診所
  • 醫院
    • 私立醫院
    • 公立醫院

第15章 人工尿道括約肌市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 人工尿道括約肌市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 人工尿道括約肌市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Affluent Medical
  • Albyn Medical Ltd.
  • Andromeda Medizinische Systeme GmbH
  • Anhui Longterm Medical Products Co., Ltd.
  • Boston Scientific Corporation
  • Dualis MedTech GmbH
  • GT Urological LLC
  • LABORIE Medical Technologies Inc.
  • MyoPowers Medical Technologies SAS
  • Promedon SA
  • Rigicon Inc.
  • Uromedical AG
  • UroMems
  • Zephyr Surgical Implants AG
Product Code: MRR-432CBFF6F3AA

The Artificial Urinary Sphincters Market is projected to grow by USD 763.18 million at a CAGR of 7.46% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 460.99 million
Estimated Year [2026] USD 497.51 million
Forecast Year [2032] USD 763.18 million
CAGR (%) 7.46%

Artificial urinary sphincters (AUS) are implantable continence devices used primarily for moderate-to-severe stress urinary incontinence, especially in men after prostate cancer treatment or other sphincter-compromising surgery. The category is clinically important because stress urinary incontinence can limit mobility, work participation, sleep, mental health, and long-term quality of life, creating a sustained need for reliable urological implants and reconstructive continence care.

In urology guidelines and peer-reviewed clinical practice, the AUS remains the reference standard for appropriately selected men with severe post-prostatectomy incontinence. Demand is shaped by aging populations, prostate cancer survivorship, higher expectations for quality-of-life restoration, and broader access to reconstructive urology. Growth is also tied to surgeon training, reimbursement coverage, infection-control protocols, and device durability, because artificial urinary sphincter implantation requires specialized patient selection, operative skill, patient education on device use, and lifelong follow-up for revision, infection, erosion, or mechanical performance concerns.

Transformative Shifts in the AUS Landscape

The artificial urinary sphincter landscape is shifting from procedure availability toward measurable outcomes, patient-reported improvement, and lifecycle management. Hospitals and ambulatory surgery centers are increasingly evaluated on complication reduction, readmission avoidance, infection prevention, and long-term device performance, making preoperative counseling and post-implant surveillance central to adoption of AUS surgery.

Technology adoption is also changing. Established hydraulic cuff systems remain the benchmark, while innovation is focused on easier activation, improved cuff design, pressure optimization, antibiotic-conscious workflows, and materials intended to reduce erosion and infection risk. The market is also influenced by the rise of male sling alternatives for selected patients, growing salvage surgery needs after pelvic radiation, greater attention to frailty and comorbidities in older patients, and wider use of telehealth for follow-up. These shifts favor stakeholders that combine durable implants, urologist education, real-world evidence generation, and structured patient support.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is not replacing the artificial urinary sphincter, but it is beginning to influence the care pathway around AUS candidates. AI-enabled analytics can support risk stratification by integrating age, prior radiation, diabetes, urethral surgery history, anticoagulation status, mobility, cognitive readiness for device operation, and severity of leakage to identify patients who may need enhanced counseling or specialized reconstructive expertise.

In clinical operations, machine learning can help forecast operating room demand, revision risk, inventory needs, and follow-up adherence. Natural language processing can extract continence outcomes, pad usage, patient-reported satisfaction, and adverse events from clinical notes, improving real-world evidence generation. AI may also support remote monitoring programs by flagging patients reporting pain, voiding difficulty, recurrent leakage, hematuria, or signs of infection. The cumulative impact is a more data-driven AUS ecosystem, where patient selection, outcome tracking, surgical planning, and revision management become more precise and scalable.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

North America remains the most established regional market for artificial urinary sphincters, supported by high prostate cancer survivorship, advanced reconstructive urology networks, and broad use of guideline-based treatment pathways. The region benefits from academic medical centers, ambulatory surgical capacity, structured continence care, and established reimbursement mechanisms for implantable urological devices. The United States is especially important because large urology groups, tertiary hospitals, cancer survivorship programs, and private and public payers create a structured environment for AUS implantation, revision surgery, infection management, and outcomes research, while Canada's access is shaped by publicly funded care pathways and provincial surgical capacity.

Europe shows mature demand for artificial urinary sphincters, with adoption concentrated in countries that have strong public reimbursement, specialized pelvic reconstructive urology, and centralized prostate cancer care. The European clinical environment emphasizes device safety, post-market surveillance, clinical evidence, and standardized quality systems. Asia-Pacific is expanding as Japan, Australia, South Korea, China, India, and ASEAN economies increase access to prostate cancer treatment, functional urology services, and tertiary surgical infrastructure, although adoption varies significantly by reimbursement, patient affordability, procurement processes, and surgeon training. Latin America, the Middle East, and Africa represent longer-term opportunities, led by private hospitals, government-funded specialty centers, and tertiary academic institutions; however, affordability, procurement reliability, specialist availability, revision-care capacity, and follow-up infrastructure remain key constraints to broader AUS adoption.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Within the European Union and G7, artificial urinary sphincter demand is supported by aging demographics, high prostate cancer diagnosis and treatment rates, established health technology assessment processes, and access to reconstructive urologists. These markets place strong emphasis on clinical evidence, device safety, surgeon credentialing, reimbursement justification, infection prevention, and post-market surveillance. NATO membership itself is not a healthcare purchasing framework, but many NATO countries overlap with high-income markets where standardized procurement, hospital quality systems, military and veteran healthcare networks, and advanced continence-care pathways can influence access to AUS implantation and revision services.

BRICS countries offer significant procedural potential because of large populations, expanding cancer care, and rising investment in specialty surgery, but adoption is uneven due to reimbursement gaps, out-of-pocket exposure, and concentration of reconstructive urology expertise in major cities. ASEAN markets are developing through private-sector growth, medical tourism hubs, and expanding tertiary urology capacity, while access remains differentiated by income level and availability of trained implanting surgeons. GCC countries benefit from government-funded tertiary care, high investment in advanced urology services, and referral-based specialist hospitals, making them important centers for premium implantable urology technologies where procurement, clinician training, and long-term service support are clearly established.

Key Country Insights Across Major AUS Markets

The United States is the leading country market for artificial urinary sphincters because of high procedural specialization, extensive prostate cancer survivorship care, broad reconstructive urology expertise, and a strong base of implanting urologists. Canada follows with publicly funded access shaped by provincial capacity, referral patterns, and wait times. Mexico and Brazil show demand in private hospitals, major academic centers, and metropolitan specialty clinics where reconstructive urology and implantable device procurement are available. In Latin America, access is closely linked to private insurance, urban specialty concentration, and the ability to support long-term revision care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from structured prostate cancer pathways, aging male populations, and experienced urology centers, although reimbursement approval, waiting lists, and regional access differ by system. Germany and France have strong specialist hospital networks, the United Kingdom emphasizes guideline-based continence management within public care, and Italy and Spain combine public hospital pathways with experienced regional centers. Russia has demand concentrated in large urban specialty hospitals where implant access and reconstructive expertise are available. In Asia-Pacific, Japan, Australia, and South Korea have advanced urology infrastructure, aging populations, and mature cancer survivorship services, while China and India represent high-potential markets where scale is significant but access depends on affordability, trained surgeons, tertiary-care availability, reimbursement expansion, and patient awareness of post-prostatectomy incontinence treatment options.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-based differentiation rather than relying only on device familiarity. The most defensible strategy is to generate long-term real-world data on continence improvement, revision rates, infection, erosion, device survival, patient satisfaction, pad-use reduction, and cost of care across diverse patient groups, including men with prior radiation, diabetes, urethral stricture history, or complex reconstructive needs.

Manufacturers and healthcare stakeholders should invest in surgeon education, proctoring, standardized implantation protocols, infection-control pathways, revision readiness, and patient activation training because AUS outcomes depend heavily on technique, appropriate selection, and follow-up. Commercial teams should align with reconstructive urology centers, cancer survivorship programs, continence clinics, and payers using value narratives that emphasize quality-of-life restoration and reduced dependence on pads or external containment. In emerging markets, success will require tiered access strategies, local distributor quality control, repair or revision support, responsible inventory management, and clear patient-selection guidance that reduces complications and supports sustainable adoption.

Research Methodology

This executive summary is built from a structured review of evidence-based sources commonly used in medical device market assessment, including urology society guidance, peer-reviewed studies on artificial urinary sphincter outcomes, regulatory and reimbursement context, hospital adoption patterns, prostate cancer survivorship trends, demographic aging indicators, and regional healthcare infrastructure evidence.

The analysis emphasizes verified clinical and market drivers rather than speculative market sizing. It evaluates demand through disease burden, treatment pathway maturity, specialist availability, reimbursement feasibility, device lifecycle needs, patient suitability, revision requirements, and real-world barriers to access. Regional, group, and country insights were synthesized by comparing healthcare capacity, urology specialization, cancer survivorship infrastructure, procurement dynamics, affordability, and follow-up systems relevant to AUS implantation and revision care.

Conclusion: The Future of Artificial Urinary Sphincters

Artificial urinary sphincters occupy a durable and clinically validated position in the management of severe stress urinary incontinence, particularly after prostate cancer treatment. The market's long-term relevance is supported by aging populations, survivorship-focused urology, patient demand for restored continence, and the continued need for specialized reconstructive solutions when conservative measures or less invasive procedures are insufficient.

The strongest opportunities will come from pairing proven device performance with better patient selection, surgeon training, outcomes analytics, and regional access strategies. As artificial intelligence, real-world evidence, and value-based care mature, AUS stakeholders that demonstrate measurable quality-of-life benefit, durable safety, responsible lifecycle support, and reliable revision-care pathways will be best positioned to lead in artificial urinary sphincter innovation and adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Artificial Urinary Sphincters Market, by Product Type

  • 7.1. Single-Cuff Artificial Urinary Sphincters
  • 7.2. Dual-Cuff Artificial Urinary Sphincters

8. Artificial Urinary Sphincters Market, by Component Type

  • 8.1. Occlusive Cuff
  • 8.2. Pressure-Regulating Balloon
  • 8.3. Control Pump
  • 8.4. Electronic Control Unit

9. Artificial Urinary Sphincters Market, by Mechanism of Action

  • 9.1. Hydraulic Pressure Control
  • 9.2. Mechanical Compression Systems
  • 9.3. Electromechanical / Sensor-Controlled Systems

10. Artificial Urinary Sphincters Market, by Material Type

  • 10.1. Silicone
  • 10.2. Polyurethane
  • 10.3. Biocompatible Polymers

11. Artificial Urinary Sphincters Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Artificial Urinary Sphincters Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Artificial Urinary Sphincters Market, by Application

  • 13.1. Neurogenic Bladder Dysfunction
  • 13.2. Stress Urinary Incontinence

14. Artificial Urinary Sphincters Market, by End User

  • 14.1. Ambulatory Surgical Centers
    • 14.1.1. Freestanding
    • 14.1.2. Hospital Affiliated
  • 14.2. Clinics
    • 14.2.1. Multispecialty Clinics
    • 14.2.2. Urology Clinics
  • 14.3. Hospitals
    • 14.3.1. Private Hospitals
    • 14.3.2. Public Hospitals

15. Artificial Urinary Sphincters Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Artificial Urinary Sphincters Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Artificial Urinary Sphincters Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Affluent Medical
  • 19.2. Albyn Medical Ltd.
  • 19.3. Andromeda Medizinische Systeme GmbH
  • 19.4. Anhui Longterm Medical Products Co., Ltd.
  • 19.5. Boston Scientific Corporation
  • 19.6. Dualis MedTech GmbH
  • 19.7. GT Urological LLC
  • 19.8. LABORIE Medical Technologies Inc.
  • 19.9. MyoPowers Medical Technologies SAS
  • 19.10. Promedon S.A.
  • 19.11. Rigicon Inc.
  • 19.12. Uromedical AG
  • 19.13. UroMems
  • 19.14. Zephyr Surgical Implants AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DUAL-CUFF ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OCCLUSIVE CUFF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PRESSURE-REGULATING BALLOON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTROL PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTROL PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTROL PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTRONIC CONTROL UNIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HYDRAULIC PRESSURE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MECHANICAL COMPRESSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELECTROMECHANICAL / SENSOR-CONTROLLED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SILICONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYURETHANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYURETHANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYURETHANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOCOMPATIBLE POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FEMALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FEMALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FEMALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MALE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MALE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MALE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROGENIC BLADDER DYSFUNCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STRESS URINARY INCONTINENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FREESTANDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FREESTANDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FREESTANDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOSPITAL AFFILIATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MULTISPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY COMPONENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA ARTIFICIAL URINARY SPHINCTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA ARTIFICIAL URINARY SPHINCTERS